Pharmacolog provides update on new business direction and proposes name change
The Board of Directors has decided to proceed with the previously communicated business change. Against this background, Pharmacolog will convene an extraordinary general meeting in the manner prescribed by the Swedish Companies Act. The Board proposes a name change to Perpetua Medical AB (publ) and a new business direction, which includes the acquisition of smaller yet profitable companies in the healthcare sector. The background to this is that progress has been made regarding the investigation of a new business direction.In February, Pharmacolog announced that the Board intended to